To learn more about our prospective biomarker study please click here.
Idylla™ MSI Available Now! Click here for more information

USCAP

March 16 - 21, 2019 | Gaylord Convention Center | Maryland

ABOUT THE CONFERENCE

BOOTH #615

The 2019 program is designed to exceed your expectations and expose you to contemporary and vibrant pathology education at its best. The Academy encourages you to make the most of this conference, designed for a broad spectrum of learning and social opportunities from the Long Course on Dermatopathology to the extraordinary Celebrate In-GEN-U-ity Party.

UPCOMING EVENTS

ASCO Annual Meeting

Fri, May 31 | South King Drive
May 31 - June 4, 2019 | Chicago, IL

ASCO 2019, 55th Annual Meeting of the American Society of Clinical Oncology will be regarding Medical, Health, Breast Cancer, Oncology, Cancer, Medical Oncology, Cancer Treatment, Immunotherapy, Colorectal Cancer, Skin Cancer, Cancer Prevention, Melanoma, Pediatric Oncology, Gynecologic Cancer and Tumor Biology.

AMP 2019 Annual Meeting

Thu, Nov 07 | Convention Center
November 7 - 9, 2019 | Baltimore Convention Center

The USCAP Annual Meeting has truly become pathology’s global event. Decision makers in the field of pathology and the related specialties of molecular, toxicology, oncology, and immunology from hospitals, private laboratories, academic institutions, and the government will be in attendance. We are continually setting records for attendance and the number of exhibitors over the past several years and look forward to doing the same in 2019.
Request A Demo

Biocartis is recruiting centers for a prospective biomarker study comparing turnaround times of standard of care methods and biomarker testing with Idylla™.

One of the biggest challenges oncology labs face with biomarker testing is the ability to obtain samples of sufficient size and quality. With the Idylla™ system only a minimal amount of sample is needed. For solid biopsies, just one slice of tissue is enough and our plasma-based assays require only 1 ml of plasma.